Genetic alteration in HRR genes may confer increased risk of multiple genetically-related malignancies, such as ovarian cancer, breast cancer, pancreatic cancers, especially BRCA1 and BRCA24,5. The gene discussed is BRCA1; the disease is ovarian carcinoma.